Investor Relations - Pharmasset, Inc. |
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Pharmasset, Inc.'s financial performance into perspective.
Recent ReleasesDec 16, 2011
Pharmasset Announces Intent to Amend QUANTUM Trial
Nov 21, 2011
Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz
